Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Lyme Arthritis Treatment Protocols Critical as Lyme Disease Spreads

Carina Stanton  |  August 15, 2018

Best Practices in Lyme Arthritis Treatment
“Humans are casual bystanders affected by this enzootic disease when bitten by an infected tick,” Dr. Steere says. In an interview, he shares four important strategies to care for patients with Lyme arthritis.

1. Know what to look for: Lyme arthritis is usually characterized by swelling and pain in one or a few large joints, especially the knee. However, small joints, bursae or tendons are sometimes affected, but usually only in one or two locations, Dr. Steere explains.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The major way to confirm the diagnosis of Lyme arthritis is by serologic testing using a two-test approach of ELISA and Western blot. Patients with Lyme arthritis have high IgG antibody responses to B. burgdorferi, as determined by ELISA, with expansion of the response to many spirochetal proteins, as shown by Western blotting. PCR testing for B. burgdorferi DNA in joint fluid is an optional test to help confirm the diagnosis. This test is positive in about 70% of patients with Lyme arthritis prior to antibiotic therapy.

2. Apply a standardized treatment algorithm: “We follow an algorithm for the treatment of Lyme arthritis,” Dr. Steere says.7 This treatment starts with oral doxycycline or amoxicillin for four weeks. “If the joint remains quite swollen, we treat with IV antibiotic therapy, usually ceftriaxone, for four weeks. If a proliferative synovitis persists or worsens after both oral and IV antibiotic therapy, we then give disease-modifying antirheumatic drug therapy.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

He says this algorithm is important to follow for all patients in an effort to treat the infection adequately, but change to anti-inflammatory therapy if the arthritis persists after oral and IV antibiotics. In such patients, persistent synovitis appears to be due to immune-mediated inflammation, with autoimmune features, that persists after spirochetal killing with antibiotic therapy.

3. Follow established testing protocols to track treatment response: After spirochetal killing occurs, Dr. Steere says the IgG antibody titer to B. burgdorferi declines gradually over a period of months. However, the ELISA test usually remains positive for years, albeit at lower titer. The Western blot, a non-quantitative test, does not change much after treatment. Accurate determination of the decline in titer requires testing longitudinal samples in the same assay, but in most instances, previous samples are not saved. The PCR test may also remain positive for weeks or maybe months after spirochetal eradication.

“There are currently no biomarkers that clearly distinguish the infectious from the post-infectious phase of the illness at the time of transition from one phase to the other. However, there are tests that can help give us clues,” Dr. Steere says.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Conditions Tagged with:best practicesBorrelia burgdorferiLyme arthritisLyme Disease

Related Articles
    The Patient's Choice

    When Rheumatologists Are a Patient’s Second or Third Choice for Medical Opinion

    September 7, 2016

    Outside Exam Room No. 5, the chart rack was empty, so I assumed my new consult was late. Just in case, I looked back over my shoulder as I passed by the partially open door and glimpsed the lower half of a woman holding a three-ringed binder on her lap. I squinted and took a…

    David M. Phillips / Science Source

    Lyme Arthritis: Presentation, Diagnosis & Treatment

    July 18, 2019

    A 52-year-old man living in greater Boston with a history of hyper­tension presented at our rheumatology clinic with bilateral knee pain and swelling. He had been in his usual state of health until four months earlier when he developed right knee pain and swelling without an incipient trauma, which did not improve with non-steroidal anti-inflammatory…

    Rheuminations: How Tiny Ticks Have Fueled Outrage and Acrimony in Some Communities

    August 1, 2013

    A history of rheumatologists’ efforts to diagnose Lyme disease

    Diagnosis, Treatment Updates for Lyme Arthritis

    July 14, 2017

    CHICAGO—A clustering of cases in Lyme, Conn., in 1975 led to the discovery of Lyme disease. Allen C. Steere, MD, professor of medicine at Harvard Medical School in Boston, investigated that outbreak, and he shared his knowledge of Lyme disease with rheumatologists gathered at the ACR’s State-of-the-Art Clinical Symposium in April. He explained that Lyme arthritis…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences